Breathizen Reviews: Announces U.S. Availability of Liquid Dietary Supplement Featuring Five Botanical Ingredients

Breathizen is positioned as a dietary supplement intended to complement a broader wellness routine.

New York City, NY, September 13, 2026 — Breathizen has announced the U.S. availability of its liquid-format dietary supplement, introducing a botanical formula that combines mullein leaf extract, ginger root extract, bromelain powder, organic lemon extract and organic Cordyceps militaris fruit extract.

The product is manufactured in the United States and is designed for oral use. According to the company’s published directions, the liquid formula is administered as four pumps, representing approximately 0.60 mL, once daily.

Breathizen is positioned as a dietary supplement intended to complement a broader wellness routine. The company does not position the product as a replacement for medical evaluation, prescription medication or treatment for respiratory disease.

The launch also places greater emphasis on distinguishing between established information about individual botanical ingredients and claims that could incorrectly imply that research on a single ingredient automatically demonstrates the effectiveness of a finished multi-ingredient supplement.

That distinction is particularly important in the dietary supplement category. The U.S. Food and Drug Administration differentiates structure/function and general-well-being statements from claims that a product can diagnose, mitigate, treat, cure or prevent a disease. Structure/function claims also require appropriate substantiation and cannot be used to imply that a dietary supplement is an approved medical treatment.

“At Breathizen, our mission is to support everyday human wellness through formula transparency and grounded botanical science. We believe consumers deserve to know not only what goes into their daily wellness routine, but also the true research context behind each ingredient, empowering them to make informed and confident choices for their health.” said Kevin Shaw, Product Head at Breathizen.

Understanding the Five Ingredients in Breathizen

Breathizen’s current formulation information identifies five principal botanical or naturally derived ingredients: mullein leaf extract 10:1, ginger root extract, bromelain powder, organic lemon extract and organic Cordyceps militaris fruit extract.

Each ingredient has a different research history. Some, such as ginger, have been evaluated in a substantial body of human clinical research. Others, including mullein and Cordyceps militaris, have longstanding traditional-use histories or emerging areas of research but considerably less clinical evidence for many of the outcomes with which they are popularly associated.

The company says consumers should not assume that inclusion of these ingredients means Breathizen itself has been clinically demonstrated to produce every outcome investigated in studies of individual ingredients.

Mullein Leaf Extract: Traditional Botanical Use With Limited Human Clinical Evidence

Mullein refers to plants in the Verbascum genus and has a long history of use in traditional herbal preparations.

Breathizen identifies a 10:1 mullein leaf extract as one component of its formula. Traditional herbal use has frequently associated mullein with the respiratory system. Scientific reviews have documented this history and identified compounds in Verbascum species including saponins, flavonoids and other phytochemicals.

However, traditional use and clinical evidence are not the same thing. A review available through the U.S. National Library of Medicine noted that mullein has historically been used for a wide range of respiratory complaints but also stated that clinical trials supporting many of those traditional uses were lacking.

That makes the appropriate interpretation of mullein substantially narrower than claims sometimes seen in consumer advertising. Breathizen therefore does not rely on mullein’s traditional history to claim that the finished product treats bronchitis, asthma, respiratory infection, chronic cough, congestion or other medical conditions.

Instead, mullein can be described accurately as a botanical with a long traditional-use history that remains an area of scientific interest. The distinction also illustrates a broader issue within botanical research: chemical constituents identified in a plant, laboratory findings involving those constituents, traditional practices and results from randomized human clinical trials represent different levels of evidence. Evidence at one level should not automatically be presented as proof at another.

Ginger Root Extract: A Botanical With a Substantial Human Research Record

Ginger, scientifically known as Zingiber officinale, is one of the more extensively researched ingredients in the Breathizen formula. It has been consumed globally as both a culinary ingredient and traditional botanical for centuries.

A systematic review examining 109 randomized controlled trials involving ginger found research across areas including nausea and vomiting, gastrointestinal function, inflammatory measures, pain and metabolic outcomes. The authors reported comparatively consistent findings in some areas, particularly certain forms of nausea, while emphasizing limitations including small study populations, inconsistent preparations and variation in study quality.

A later umbrella review evaluating systematic reviews of orally consumed ginger similarly found that evidence strength differed considerably by outcome. The strongest evidence was associated with certain anti-nausea applications, while evidence involving inflammatory, metabolic and other endpoints ranged from very low to moderate certainty depending on the outcome.

These findings establish ginger as a botanical with meaningful human research behind it. They do not, however, establish that ginger root extract in Breathizen improves lung capacity, increases oxygen levels, removes toxins from the lungs or treats respiratory inflammation.

Those would represent a substantially different set of claims requiring appropriate product-specific substantiation. For general wellness discussions, ginger is better understood as a widely consumed botanical containing compounds such as gingerols and shogaols that have attracted significant scientific study.

That evidence can provide legitimate context for why ginger remains a common ingredient in modern botanical formulations without transforming Breathizen into a treatment for a respiratory condition.

Bromelain: A Pineapple-Derived Proteolytic Enzyme

Bromelain is another ingredient included in Breathizen. The term refers to a group of proteolytic enzymes obtained primarily from pineapple, or Ananas comosus. Proteolytic enzymes participate in the breakdown of proteins into smaller components.

Research literature surrounding bromelain has investigated its biochemical properties and potential effects in several areas of human health. Reviews describe bromelain as a complex enzyme preparation and discuss research involving inflammatory processes, digestion and other physiological pathways.

However, bromelain research involves different preparations, concentrations, delivery methods, populations and study designs. This means findings involving a particular standardized bromelain preparation cannot simply be transferred to every supplement containing bromelain.

Breathizen therefore does not characterize bromelain as an ingredient that has been clinically established to “dissolve mucus,” eliminate chest congestion or repair respiratory tissue when consumed as part of the Breathizen formula. Instead, the company identifies bromelain for what it is: a pineapple-derived proteolytic enzyme with a substantial history of biochemical and clinical research.

That narrower description allows the ingredient’s scientific background to be discussed without presenting preliminary or formulation-specific research as a guaranteed consumer outcome.

Organic Lemon Extract: Citrus Phytochemicals in a Botanical Formula

Lemon, or Citrus limon, is familiar primarily as a food, but citrus fruits also contain a range of naturally occurring compounds that have been studied by food scientists and other researchers. A scientific review of Citrus limon described lemon-derived materials as containing phenolic compounds, including flavonoids and phenolic acids, while lemon essential oil contains various monoterpenoids.

These compounds have contributed to research interest surrounding citrus ingredients. An important limitation is that “lemon extract” is not a standardized description of one universal chemical composition. The amount and type of compounds present can vary according to which part of the plant is used, extraction method, concentration and processing.

For the same reason, the presence of organic lemon extract in Breathizen should not automatically be interpreted as a specified dose of vitamin C unless a quantified amount of vitamin C is provided on the product’s Supplement Facts label. Breathizen therefore avoids representing the lemon extract component as proof that the product strengthens immunity, detoxifies the lungs or prevents respiratory illness.

Its inclusion can instead be described as part of the formula’s botanical profile and as a source material known to contain naturally occurring citrus phytochemicals.

Cordyceps militaris: Emerging Human Research With Important Limitations

The fifth principal ingredient identified in Breathizen is organic Cordyceps militaris fruit extract. Cordyceps species have a long history within traditional practices in parts of Asia and have attracted growing scientific attention. Modern research has examined Cordyceps-related preparations for areas ranging from exercise performance and fatigue to immune and metabolic pathways.

Human evidence, however, remains much smaller than the volume of laboratory and animal research might suggest. A 2026 narrative review examining Cordyceps militaris supplementation in healthy individuals identified five eligible intervention studies published between 2017 and 2024, involving a total of 321 participants.

The researchers reported substantial variation in intervention duration and dosage and characterized the available human results involving exercise performance and recovery as limited and inconsistent. That limitation is particularly relevant for consumer communication.

Research involving physical performance should not be converted into a statement that Breathizen increases lung capacity, improves cellular oxygenation or produces greater respiratory endurance. Those are specific product-outcome claims that would require evidence directly supporting them. Instead, the inclusion of Cordyceps militaris can be discussed as part of an emerging area of nutritional and botanical research.

The existing research provides scientific context for interest in the ingredient while leaving substantial room for additional well-controlled human studies.

Why Ingredient Research Is Different From Finished-Product Evidence

Breathizen’s approach to ingredient communication centers on an important principle: a study involving an ingredient is not automatically a clinical study of the finished product. Several variables can affect whether findings from ingredient research apply to a commercial formulation.

These include the amount of each ingredient, botanical species, plant part, extraction process, standardization method, route of administration, duration of use, characteristics of the population studied and interactions with other ingredients. For example, a randomized trial involving a measured gram-level dose of ginger cannot by itself establish the effects of a multi-ingredient liquid formula simply because that formula includes ginger.

Similarly, laboratory findings involving isolated compounds from a botanical do not establish that a consumer will experience the same biological outcome after taking a supplement containing an extract of that botanical. This distinction is particularly important for botanical supplements because scientific literature can include everything from cell-culture experiments and animal models to observational studies and randomized placebo-controlled human trials.

Each design answers a different type of scientific question. Breathizen says its ingredient overview is intended to give consumers useful context without presenting an ingredient bibliography as proof of clinical efficacy for the complete formula.

General Wellness Rather Than Disease Treatment

Breathizen is marketed as a dietary supplement, not a drug. According to FDA guidance, dietary supplement structure/function claims may describe how a nutrient or dietary ingredient is intended to affect the normal structure or function of the human body, provided appropriate requirements are met. They cannot claim that a supplement diagnoses, treats, cures, mitigates or prevents a specific disease.

Accordingly, Breathizen should not be interpreted as a treatment for asthma, chronic obstructive pulmonary disease, pneumonia, bronchitis, influenza, allergies, respiratory infection or another diagnosed condition. It should also not be used as a substitute for inhalers, prescription drugs, oxygen therapy or other care prescribed by a healthcare professional.

Shortness of breath, persistent coughing, unexplained chest pain, wheezing, reduced exercise tolerance and other respiratory symptoms can have numerous causes and may require medical evaluation. Consumers experiencing significant or persistent symptoms should consult an appropriate healthcare professional.

A Broader Move Toward Responsible Supplement Communication

The dietary supplement market has increasingly placed ingredient names, scientific terminology and research references at the center of consumer marketing. That can give consumers more information, but it can also create confusion when research findings are presented without their limitations.

Breathizen’s expanded ingredient discussion is intended to differentiate among three separate ideas: what an ingredient is, what researchers have investigated about that ingredient and what has actually been demonstrated about the complete Breathizen formulation. Those categories are not interchangeable.

The presence of ginger does not mean every ginger research result applies to Breathizen. The presence of bromelain does not mean the supplement has proven therapeutic effects. Traditional use of mullein does not establish modern clinical efficacy. Citrus phytochemicals do not establish a quantified antioxidant outcome. Emerging Cordyceps research does not establish improvements in respiratory capacity. This distinction allows consumers to evaluate the formula with more realistic expectations.

Product Format and Availability

Breathizen is offered in a liquid format and is manufactured in the United States, according to the company’s published information. Current company instructions state that users should shake the product before use and administer four pumps, approximately 0.60 mL, orally once daily.

Consumers should rely on the physical product label and current Supplement Facts panel for definitive serving information, ingredient quantities, directions and warnings.

Individuals who are pregnant or breastfeeding, taking prescription medication, preparing for surgery, managing an existing medical condition or using other dietary supplements should discuss supplementation with a qualified healthcare professional where appropriate. Botanical ingredients and dietary supplements can interact with medications or may not be appropriate for every individual.

About Breathizen

Breathizen is a U.S.-manufactured liquid dietary supplement containing a combination of botanical extracts and naturally derived ingredients. The formula currently identifies mullein leaf extract 10:1, ginger root extract, bromelain powder, organic lemon extract and organic Cordyceps militaris fruit extract.

The company states that its goal is to provide consumers with accessible information about its formula while distinguishing general ingredient research from product-specific clinical evidence.

Additional product information is available at mybreathizen.com.

Research Context Referenced in This Release

Research discussed in this release includes reviews indexed by the U.S. National Library of Medicine examining ginger, mullein, bromelain, lemon and Cordyceps militaris. The research relates to individual ingredients and should not be interpreted as a clinical evaluation or endorsement of Breathizen.

Among the research sources consulted were systematic reviews of randomized ginger trials, reviews of bromelain literature, botanical literature concerning Verbascum species, a review of Citrus limon chemistry and biological activity, and a recent review of human Cordyceps militaris exercise studies.

No source referenced in this release should be interpreted as an endorsement of Breathizen by the researchers, journals, National Institutes of Health, National Library of Medicine, Food and Drug Administration or another government agency.

Important Consumer Notice

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This release provides general information about dietary ingredients and published research and is not medical advice. Research involving an individual ingredient does not establish that Breathizen produces the same outcome.

Media Contact

Kevin Shaw, Product Head at Breathizen
Email: support@mybreathizen.com
Address: 1201 N Orange Street, Lakeland, FL 33804
Website: https://mybreathizen.com/

For more press release distribution and guest post services, visit TS Newswire.